MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients’ prognosis.

MLA

Xu, Y., et al. “MiR-592 Functions as a Tumor Suppressor in Acute Myeloid Leukemia by Targeting ROCK1 and Predicts Patients’ Prognosis.” European Review for Medical & Pharmacological Sciences, vol. 23, no. 4, Feb. 2019, pp. 1610–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=135145979&authtype=sso&custid=ns315887.

APA

Xu, Y., Li, K., Wang, S.-B., & Yang, S.-G. (2019). MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients’ prognosis. European Review for Medical & Pharmacological Sciences, 23(4), 1610–1619.

Chicago

Xu, Y., K. Li, S.-B. Wang, and S.-G. Yang. 2019. “MiR-592 Functions as a Tumor Suppressor in Acute Myeloid Leukemia by Targeting ROCK1 and Predicts Patients’ Prognosis.” European Review for Medical & Pharmacological Sciences 23 (4): 1610–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=135145979&authtype=sso&custid=ns315887.